Health Condition 1: H350- Background retinopathy and retinalvascular changes Health Condition 2: H350- Background retinopathy and retinalvascular changes
Conditions
Interventions
None listed
Sponsors
Parul University
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with a history of 10 years or more duration of type 2 diabetes Mellitus are taken for the study with oral hypoglycemic drugs or insulin. 2. Patients with symptoms like blurred vision, fluctuating vision, gradual vision loss, cloudy or hazy vision, and flashes of lights are included. 3. Patients with fundus changes as seen through the direct ophthalmoscope after dilating the eye like small dot and blot hemorrhages, multiple cotton wool spots, vascular changes such as venous beading, attenuation of the arterioles, venous loop, dilatation of veins are included.
Exclusion criteria
Exclusion criteria: 1. Patients with proliferative diabetic retinopathy, high-risk diabetic retinopathy, advanced diabetic eye diseases, other vascular retinopathies like hypertensive retinopathy, retinopathy of blood dyscrasias, gestational diabetic retinopathy, retinopathy of prematurity, sickle cell retinopathy are excluded. 2. patients with other systemic disorders like renal diseases, chronic hyperglycemia, hyper lipidemia, and cardiovascular diseases are excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Combined effect of takra dhara shirodhara and nayanasukha varthi as anjana karma is effective for the management of early to moderate stages of non proliferative diabetic retinopathyTimepoint: 2 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Combined effect of takradhara & nayanasukha varthi anjana with contemporary anti-glycemic drugs in the early to moderate stage of non proliferative diabetic retinopathyTimepoint: 2 months | — |
Countries
India
Contacts
Public ContactDr.Manjiri Keskar
Dept of Shalakya Tantra
Outcome results
None listed